Through randomization using a randomization table, patients are classified as either Treatment group in maximally dilated coronary artery administered with nitrate formulation or General treatment group without nitrate preparation (control group) to evaluate whether there is a difference in diameter of the treated Ultimaster® stent and to evaluate the stability and effectiveness after the procedure.
Not Applicable
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0006423
- Lead Sponsor
- Inha University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
1. Coronary Artery Disease
2. Vessle diameter 2.25~3.5mm, stenosis upper 50%
3. Those who voluntarily agreed in writing to participate in this clinical trial
Exclusion Criteria
1. Hemodynamic instability or psychogenic shock within 24 hours before Percutaneous Coronary Intervention (PCI)
2. Life expectancy within 1 year
3. If other investigators judge that it is inappropriate to participate in this study
4. Patients who cannot use vasodilators (nitrate preparations)
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Average diameter diameter of the inserted stent
- Secondary Outcome Measures
Name Time Method thrombosis;1-year target vascular failure rate;1-year heart death rate; 1-year myocardial infarction rate